lots of COVID testing going on and for at least a year which certainly will affect earnings. Organic acquisitions all from cash flow/debt and are insignificant on the balance sheet due to low debt/equity ratio. Strong buy however it's a defensive stock so $4.25-50 price target and will stay there for at least a year without much more appreciation thereafter . yield roughly 3.9% allowing for COVID testing profit increase DYOR
lots of COVID testing going on and for at least a year which...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.82 |
Change
-0.010(0.35%) |
Mkt cap ! $553.8M | |||
| Open | High | Low | Value | Volume |
| $2.83 | $2.83 | $2.78 | $1.879M | 670.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1071 | $2.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.83 | 2376 | 2 |
View Market Depth
| Last trade - 16.14pm 29/07/2025 (20 minute delay) ? |
| ACL (ASX) Chart |